We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.27B
AUM Growth
-$46.7M
Cap. Flow
-$431M
Cap. Flow %
-13.18%
Top 10 Hldgs %
56.15%
Holding
134
New
19
Increased
35
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$44.1M
2
FCFS icon
FirstCash
FCFS
+$26.4M
3
SNDX icon
Syndax Pharmaceuticals
SNDX
+$20.4M
4
FTIVU
FinTech Acquisition Corp. IV Unit
FTIVU
+$20M
5
AKU
Akumin Inc
AKU
+$17.2M

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$39.3M
2
MED icon
Medifast
MED
+$37.9M
3
THC icon
Tenet Healthcare
THC
+$37.4M
4
HCA icon
HCA Healthcare
HCA
+$30.4M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$22.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.92%
2 Consumer Discretionary 6.06%
3 Industrials 4.77%
4 Technology 4.5%
5 Financials 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$674M 20.62%
4,500,000
+400,000
+10% +$60.2M
W icon
2
CALL
Wayfair
W
$11.2B
$379M 11.61%
1,304,000
– –
CVNA icon
3
CALL
Carvana
CVNA
$68.6B
$231M 7.06%
5,174,000
-3,838,000
-43% -$136M
LNW
4
CALL
DELISTED
Light & Wonder
LNW
$151M 4.62%
4,328,600
– –
IWM icon
5
CALL
iShares Russell 2000 ETF
IWM
$79.8B
$105M 3.21%
700,000
-500,000
-42% -$75.2M
CDXS icon
6
Codexis
CDXS
$151M
$63M 1.93%
5,363,484
– –
DLB icon
7
Dolby
DLB
$5.51B
$62.2M 1.9%
938,656
+8,463
+0.9% +$573K
THC icon
8
CALL
Tenet Healthcare
THC
$20.5B
$58.9M 1.8%
2,402,500
– –
QURE icon
9
uniQure
QURE
$3.03B
$58.3M 1.78%
1,583,358
+15,209
+1% +$623K
VG
10
DELISTED
Vonage Holdings Corporation
VG
$53M 1.62%
5,183,712
+50,412
+1% +$559K
QADA
11
DELISTED
QAD Inc.
QADA
$50M 1.53%
1,184,365
+10,497
+0.9% +$441K
VAC icon
12
Marriott Vacations Worldwide
VAC
$3.35B
$47.9M 1.47%
527,683
-13,950
-3% -$1.27M
APTO
13
DELISTED
Aptose Biosciences, Inc.
APTO
$41.3M 1.26%
15,309
+2,027
+15% +$5.05M
TNL icon
14
Travel + Leisure Co
TNL
$4.66B
$40.1M 1.23%
1,304,435
+310,496
+31% +$9.27M
CAR icon
15
PUT
Avis
CAR
$4.86B
$39.5M 1.21%
1,500,000
– –
QURE icon
16
CALL
uniQure
QURE
$3.03B
$39.1M 1.2%
1,062,500
– –
TFFP
17
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$37.5M 1.15%
81,320
+47,059
+137% +$13.3M
ESTA icon
18
Establishment Labs
ESTA
$2.72B
$35.6M 1.09%
1,919,190
+11,477
+0.6% +$204K
CUE icon
19
Cue Biopharma
CUE
$113M
$35.3M 1.08%
78,074
+561
+0.7% +$323K
BMY.RT
20
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$34.7M 1.06%
+15,437,336
New +$44.1M
CASH icon
21
Pathward Financial
CASH
$1.86B
$34.6M 1.06%
1,799,727
– –
IMXI icon
22
International Money Express
IMXI
$357M
$33.3M 1.02%
2,318,668
-594,022
-20% -$9.06M
FBIO icon
23
Fortress Biotech
FBIO
$104M
$33.2M 1.02%
548,329
+253,333
+86% +$12.9M
GDEN
24
DELISTED
Golden Entertainment
GDEN
$29.4M 0.9%
2,127,788
– –
LXFR icon
25
Luxfer Holdings
LXFR
$456M
$28.6M 0.87%
2,277,665
+24,193
+1% +$329K
1
2 3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return

Nantahala Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Nantahala Capital Management held 134 positions worth $3.27B, down 1.4% from $3.32B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management withdrew a net $431M in Q3 2020, closing 20 positions and reducing 23 holdings. Its most notable exit was RH, an estimated $39.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Nantahala Capital Management opened a new position in Bristol-Myers Squibb Company Contingent Value Rights worth $34.7M.

  • Nantahala Capital Management's largest Q3 2020 buy was Bristol-Myers Squibb Company Contingent Value Rights: 15,437,336 shares worth $34.7M.
  • Nantahala Capital Management added most to TravelCenters of America LLC in Q3 2020, an estimated $16.5M increase.
  • Nantahala Capital Management's biggest Q3 2020 reduction was Tenet Healthcare, cutting an estimated $37.4M.
  • Nantahala Capital Management fully exited RH in Q3 2020, selling an estimated $39.3M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $3.27B portfolio in Q3 2020.
  • Nantahala Capital Management opened 19 new positions and closed 20 in Q3 2020.
  • Nantahala Capital Management's portfolio value fell 1.4% quarter-over-quarter to $3.27B.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.